research use only
Cat.No.S5775
| Related Targets | CFTR CRM1 CD markers AChR Calcium Channel Sodium Channel Potassium Channel GABA Receptor TRP Channel ATPase |
|---|---|
| Other ROR Inhibitors | GSK2981278 Cintirorgon (LYC-55716) SR1001 Neoruscogenin SR3335 TMP778 Cedirogant S18-000003 |
| Molecular Weight | 431.25 | Formula | C17H10F9NO2 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 1246525-60-9 | -- | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1=CC(=CC=C1C(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O)C(F)(F)F | ||
|
In vitro |
DMSO
: 86 mg/mL
(199.42 mM)
Ethanol : 86 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Targets/IC50/Ki |
RORα
RORγ
|
|---|---|
| In vitro |
SR1078 modulates the conformation of RORγ in a biochemical assay and activates RORα and RORγ driven transcription. This compound stimulates expression of endogenous ROR target genes in HepG2 cells that express both RORα and RORγ.
|
| In vivo |
SR1078 displays pharmacokinetic properties that allow it to be used in vivo.
|
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.